(Q42955589)

11 November 2017

title

Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial (English)

1 reference

11 November 2017

Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: Results of a prospective multicenter open-label trial (English)

1 reference

https://api.crossref.org/works/10.1016/J.CLINEURO.2010.06.018

multicenter clinical trial

11 June 2024

main subject

myasthenia gravis

0 references

1 reference

1 reference

Jörn Peter Sieb

1

1 reference

11 November 2017

Wolfgang Köhler

2

1 reference

11 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20663605

11 June 2024

publication date

21 July 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S0303846710001952?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CLINEURO.2010.06.018

https://api.elsevier.com/content/article/PII:S0303846710001952?httpAccept=text/plain

11 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.CLINEURO.2010.06.018

Clinical Neurology and Neurosurgery

11 June 2024

published in

1 reference

11 November 2017

volume

112

1 reference

11 November 2017

issue

9

1 reference

11 November 2017

page(s)

781-784

1 reference

Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CLINEURO.2010.06.018

Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravis

11 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CLINEURO.2010.06.018

The pharmacokinetics of pyridostigmine

11 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CLINEURO.2010.06.018

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

11 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CLINEURO.2010.06.018

Quantitative correlation between plasma pyridostigmine levels and neuromuscular function in myasthenia gravis

11 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CLINEURO.2010.06.018

[Serum levels of pyridostigmine in myasthenia gravis: methods and clinical significance]

11 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CLINEURO.2010.06.018

EuroQol--a new facility for the measurement of health-related quality of life

11 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CLINEURO.2010.06.018

Plasma pyridostigmine levels in myasthenia gravis

11 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CLINEURO.2010.06.018

11 June 2024

Identifiers

1 reference

release_efzfsmshrzhzpcqhigxo6bqb4q

11 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/efzfsmshrzhzpcqhigxo6bqb4q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference